OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Swedish Orphan Biovitrum AB/  SE0000872095  /

Cboe Europe DXE
5/3/2024  5:24:07 PM Chg. -0.60 Volume Bid5:25:00 PM Ask5:25:00 PM Market Capitalization Dividend Y. P/E Ratio
279.60SEK -0.21% 252,093
Turnover: 47.08 mill.		 -Bid Size: - -Ask Size: - 99.22 bill.SEK - 37.48
GlobeNewswire 5/1 ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on...
GlobeNewswire 4/4 ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination wit...
GlobeNewswire 4/3 ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024
GlobeNewswire 4/1 Autolus Therapeutics Announces Changes to its Board of Directors
GlobeNewswire 3/28 Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
GlobeNewswire 3/13 ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business U...
GlobeNewswire 3/6 ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
GlobeNewswire 3/6 ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March...
GlobeNewswire 3/5 ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cance...
GlobeNewswire 1/4 ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards
GlobeNewswire 1/4 ADC Therapeutics Provides Business Updates
GlobeNewswire 12/12/2023 ADC Therapeutics Announces Initial Results from Investigator-Initiated Phase 2 Clinical Trial Evalua...
GlobeNewswire 11/7/2023 ADC Therapeutics Receives NYSE Notice of Non-Compliance With Continued Listing Standards
GlobeNewswire 11/7/2023 ADC Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
GlobeNewswire 11/6/2023 Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia
GlobeNewswire 11/6/2023 ADC Therapeutics to Participate in the Jefferies London Healthcare Conference
GlobeNewswire 11/2/2023 Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies fo...
GlobeNewswire 11/2/2023 ADC Therapeutics Announces Abstracts Accepted for Presentation at the 65th ASH Annual Meeting
GlobeNewswire 11/1/2023 Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer
GlobeNewswire 10/31/2023 Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Comme...
GlobeNewswire 10/24/2023 ADC Therapeutics to Host Third Quarter 2023 Financial Results Conference Call on November 7, 2023
GlobeNewswire 9/5/2023 ADC Therapeutics to Participate in September Investor Conferences
GlobeNewswire 8/31/2023 ADC Therapeutics Announces Updates on ZYNLONTA® LOTIS Clinical Trial Programs at the Eleventh Annual...
Newsfile Corp 8/23/2023 SEC Charges Former Attorney at U.S.-Based Global Law Firm with Insider Trading
GlobeNewswire 8/17/2023 Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiativ...